BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

571 related articles for article (PubMed ID: 30246251)

  • 1. Bone morphogenetic protein receptor signal transduction in human disease.
    Gomez-Puerto MC; Iyengar PV; García de Vinuesa A; Ten Dijke P; Sanchez-Duffhues G
    J Pathol; 2019 Jan; 247(1):9-20. PubMed ID: 30246251
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bone morphogenetic proteins.
    Chen D; Zhao M; Mundy GR
    Growth Factors; 2004 Dec; 22(4):233-41. PubMed ID: 15621726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The unique activity of bone morphogenetic proteins in bone: a critical role of the Smad signaling pathway.
    Katagiri T; Tsukamoto S
    Biol Chem; 2013 Jun; 394(6):703-14. PubMed ID: 23324379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in BMP receptor signaling.
    Sieber C; Kopf J; Hiepen C; Knaus P
    Cytokine Growth Factor Rev; 2009; 20(5-6):343-55. PubMed ID: 19897402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mode of bone morphogenetic protein (BMP) receptor oligomerization determines different BMP-2 signaling pathways.
    Nohe A; Hassel S; Ehrlich M; Neubauer F; Sebald W; Henis YI; Knaus P
    J Biol Chem; 2002 Feb; 277(7):5330-8. PubMed ID: 11714695
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Competition between type I activin and BMP receptors for binding to ACVR2A regulates signaling to distinct Smad pathways.
    Szilágyi SS; Amsalem-Zafran AR; Shapira KE; Ehrlich M; Henis YI
    BMC Biol; 2022 Feb; 20(1):50. PubMed ID: 35177083
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic protein receptors: Structure, function and targeting by selective small molecule kinase inhibitors.
    Sanchez-Duffhues G; Williams E; Goumans MJ; Heldin CH; Ten Dijke P
    Bone; 2020 Sep; 138():115472. PubMed ID: 32522605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural insights into BMP receptors: Specificity, activation and inhibition.
    Yadin D; Knaus P; Mueller TD
    Cytokine Growth Factor Rev; 2016 Feb; 27():13-34. PubMed ID: 26690041
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PP2A regulates BMP signalling by interacting with BMP receptor complexes and by dephosphorylating both the C-terminus and the linker region of Smad1.
    Bengtsson L; Schwappacher R; Roth M; Boergermann JH; Hassel S; Knaus P
    J Cell Sci; 2009 Apr; 122(Pt 8):1248-57. PubMed ID: 19339557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. BMP signaling in vascular diseases.
    Cai J; Pardali E; Sánchez-Duffhues G; ten Dijke P
    FEBS Lett; 2012 Jul; 586(14):1993-2002. PubMed ID: 22710160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Signal transduction pathway through activin receptors as a therapeutic target of musculoskeletal diseases and cancer.
    Tsuchida K; Nakatani M; Uezumi A; Murakami T; Cui X
    Endocr J; 2008 Mar; 55(1):11-21. PubMed ID: 17878607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Promoting bone morphogenetic protein signaling through negative regulation of inhibitory Smads.
    Itoh F; Asao H; Sugamura K; Heldin CH; ten Dijke P; Itoh S
    EMBO J; 2001 Aug; 20(15):4132-42. PubMed ID: 11483516
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dysregulation of the BMP-p38 MAPK signaling pathway in cells from patients with fibrodysplasia ossificans progressiva (FOP).
    Fiori JL; Billings PC; de la Peña LS; Kaplan FS; Shore EM
    J Bone Miner Res; 2006 Jun; 21(6):902-9. PubMed ID: 16753021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Variant BMP receptor mutations causing fibrodysplasia ossificans progressiva (FOP) in humans show BMP ligand-independent receptor activation in zebrafish.
    Mucha BE; Hashiguchi M; Zinski J; Shore EM; Mullins MC
    Bone; 2018 Apr; 109():225-231. PubMed ID: 29307777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.
    Sugama R; Koike T; Imai Y; Nomura-Furuwatari C; Takaoka K
    Bone; 2006 Feb; 38(2):206-14. PubMed ID: 16203197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic protein (BMP) type II receptor deletion reveals BMP ligand-specific gain of signaling in pulmonary artery smooth muscle cells.
    Yu PB; Beppu H; Kawai N; Li E; Bloch KD
    J Biol Chem; 2005 Jul; 280(26):24443-50. PubMed ID: 15883158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of the bone morphogenetic protein receptor by H11kinase/Hsp22 promotes cardiac cell growth and survival.
    Sui X; Li D; Qiu H; Gaussin V; Depre C
    Circ Res; 2009 Apr; 104(7):887-95. PubMed ID: 19246680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of Smads, the TGF-beta family intracellular signaling components during endochondral ossification.
    Sakou T; Onishi T; Yamamoto T; Nagamine T; Sampath Tk; Ten Dijke P
    J Bone Miner Res; 1999 Jul; 14(7):1145-52. PubMed ID: 10404014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A portrait of Transforming Growth Factor β superfamily signalling: Background matters.
    Horbelt D; Denkis A; Knaus P
    Int J Biochem Cell Biol; 2012 Mar; 44(3):469-74. PubMed ID: 22226817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the BMP canonical signaling pathway in human optic nerve head tissue and isolated optic nerve head astrocytes and lamina cribrosa cells.
    Zode GS; Clark AF; Wordinger RJ
    Invest Ophthalmol Vis Sci; 2007 Nov; 48(11):5058-67. PubMed ID: 17962458
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.